scispace - formally typeset
Open AccessJournal ArticleDOI

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.

TLDR
Among patients with pneumonia caused by SARS-CoV-2 (novel coronavirus pneumonia or Wuhan pneumonia), fever was the most common symptom, followed by cough, and bilateral lung involvement with ground-glass opacity was themost common finding from computed tomography images of the chest.
About
This article is published in International Journal of Antimicrobial Agents.The article was published on 2020-02-17 and is currently open access. It has received 4318 citations till now. The article focuses on the topics: Pneumonia & Outbreak.

read more

Citations
More filters
Journal ArticleDOI

Deploying Biomolecules as Anti-COVID-19 Agents

TL;DR: At present social distancing along with previously known traditional medicines can act as quick and short-term alternatives for treating this viral flu, but these proposals are time-consuming processes.
Journal ArticleDOI

SARS-CoV-2-mediated inflammatory response in lungs: should we look at RAGE?

TL;DR: This commentary intends to highlight how a new mechanism describing the RAGE transactivation produced by Ang II-mediated ATR1 activation can run continuously and thus, reinforcing a sustained inflammation in lungs, due to the SARS-Cov-2-mediated imbalance of the ACE/And II/ATR1 pathway.
Journal ArticleDOI

Experiences and management of physician psychological symptoms during infectious disease outbreaks: a rapid review.

TL;DR: The uncertainty of the ongoing COVID-19 pandemic along with increased workload and difficult medical triage decisions may lead to a further decline in physician psychological health and burnout as mentioned in this paper.
Journal ArticleDOI

Metformin and COVID-19: A novel deal of an old drug.

TL;DR: Light is shed on a new suggestion to decrease the mortality rate of COVID‐19, a global pandemic infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which has 2,709,483 confirmed cases in over 225 countries around the world.
Journal ArticleDOI

Is Nanotechnology Helping in the Fight Against COVID-19?

TL;DR: Nanotechnology-based strategies for the prevention, diagnosis, and treatment of COVID-19 are discussed, including nanomaterials for face masks and surface sterilization, adjuvants, vaccine delivery nanosystems, and point-of-care tests, providing a perspective on how nanotechnology could be an applied in the fight against COVID -19.
References
More filters
Journal ArticleDOI

A Novel Coronavirus from Patients with Pneumonia in China, 2019.

TL;DR: Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily, which is the seventh member of the family of coronaviruses that infect humans.
Journal ArticleDOI

A pneumonia outbreak associated with a new coronavirus of probable bat origin

TL;DR: Identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China, and it is shown that this virus belongs to the species of SARSr-CoV, indicates that the virus is related to a bat coronav virus.
Journal ArticleDOI

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

TL;DR: The epidemiological and clinical characteristics of novel coronavirus (2019-nCoV)-infected pneumonia in Wuhan, China, and hospital-associated transmission as the presumed mechanism of infection for affected health professionals and hospitalized patients are described.
Journal ArticleDOI

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

TL;DR: Characteristics of patients who died were in line with the MuLBSTA score, an early warning model for predicting mortality in viral pneumonia, and further investigation is needed to explore the applicability of the Mu LBSTA scores in predicting the risk of mortality in 2019-nCoV infection.
Related Papers (5)